United States Microbiome Therapeutics Market Report 2017

January 2017 | 118 pages | ID: U5346D473C7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Microbiome Therapeutics

Revenue, means the sales value of Microbiome Therapeutics

This report studies sales (consumption) of Microbiome Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• C3 Jian
• Enterome Bioscience
• Immuron
• MicroBiome Therapeutics
• OpenBiome
• Osel
• Ritter Pharmaceuticals
• Second Genome
• Seres Therapeutics
• Synthetic Biologics
• 4D Pharma
• AbbVie
• ActoGeniX
• Admera Health
• Advanced Technology Ventures
• Advancing Bio
• AgBiome
• AOBiome
• APC Microbiome Institute
• Assembly Biosciences
• Avid Biotics
• Azitra

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Probiotic Type
• Fructo-Oligosaccharides
• Galacto-Oligosaccharides
• Inulin

Split by applications, this report focuses on sales, market share and growth rate of Microbiome Therapeutics in each application, can be divided into

• Antibiotic-Associated Diarrhoea (AAD)
• Infectious Childhood Diarrhoea
• Cholesterol
• Inflammatory Bowel Disease (IBD)
• Blood Pressure
• Lactose Intolerance
• Weight Loss
• Vitamin Production
• Bacterial Vaginosis (BV)
• Others

Contents

United States Microbiome Therapeutics Market Report 2017

1 MICROBIOME THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Classification of Microbiome Therapeutics
  1.2.1 Probiotic Type
  1.2.2 Fructo-Oligosaccharides
  1.2.3 Galacto-Oligosaccharides
  1.2.4 Inulin
1.3 Application of Microbiome Therapeutics
  1.3.1 Antibiotic-Associated Diarrhoea (AAD)
  1.3.2 Infectious Childhood Diarrhoea
  1.3.3 Cholesterol
  1.3.4 Inflammatory Bowel Disease (IBD)
  1.3.5 Blood Pressure
  1.3.6 Lactose Intolerance
  1.3.7 Weight Loss
  1.3.8 Vitamin Production
  1.3.9 Bacterial Vaginosis (BV)
  1.3.10 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Microbiome Therapeutics (2012-2022)
  1.4.1 United States Microbiome Therapeutics Sales and Growth Rate (2012-2022)
  1.4.2 United States Microbiome Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES MICROBIOME THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Microbiome Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Microbiome Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Microbiome Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Microbiome Therapeutics Market Competitive Situation and Trends
  2.4.1 Microbiome Therapeutics Market Concentration Rate
  2.4.2 Microbiome Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Microbiome Therapeutics Sales and Market Share by States (2012-2017)
3.2 United States Microbiome Therapeutics Revenue and Market Share by States (2012-2017)
3.3 United States Microbiome Therapeutics Price by States (2012-2017)

4 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Microbiome Therapeutics Sales and Market Share by Type (2012-2017)
4.2 United States Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Microbiome Therapeutics Price by Type (2012-2017)
4.4 United States Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Microbiome Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MICROBIOME THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

6.1 C3 Jian
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Microbiome Therapeutics Product Type, Application and Specification
    6.1.2.1 Probiotic Type
    6.1.2.2 Fructo-Oligosaccharides
  6.1.3 C3 Jian Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Enterome Bioscience
  6.2.2 Microbiome Therapeutics Product Type, Application and Specification
    6.2.2.1 Probiotic Type
    6.2.2.2 Fructo-Oligosaccharides
  6.2.3 Enterome Bioscience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Immuron
  6.3.2 Microbiome Therapeutics Product Type, Application and Specification
    6.3.2.1 Probiotic Type
    6.3.2.2 Fructo-Oligosaccharides
  6.3.3 Immuron Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 MicroBiome Therapeutics
  6.4.2 Microbiome Therapeutics Product Type, Application and Specification
    6.4.2.1 Probiotic Type
    6.4.2.2 Fructo-Oligosaccharides
  6.4.3 MicroBiome Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 OpenBiome
  6.5.2 Microbiome Therapeutics Product Type, Application and Specification
    6.5.2.1 Probiotic Type
    6.5.2.2 Fructo-Oligosaccharides
  6.5.3 OpenBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Osel
  6.6.2 Microbiome Therapeutics Product Type, Application and Specification
    6.6.2.1 Probiotic Type
    6.6.2.2 Fructo-Oligosaccharides
  6.6.3 Osel Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ritter Pharmaceuticals
  6.7.2 Microbiome Therapeutics Product Type, Application and Specification
    6.7.2.1 Probiotic Type
    6.7.2.2 Fructo-Oligosaccharides
  6.7.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Second Genome
  6.8.2 Microbiome Therapeutics Product Type, Application and Specification
    6.8.2.1 Probiotic Type
    6.8.2.2 Fructo-Oligosaccharides
  6.8.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Seres Therapeutics
  6.9.2 Microbiome Therapeutics Product Type, Application and Specification
    6.9.2.1 Probiotic Type
    6.9.2.2 Fructo-Oligosaccharides
  6.9.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Synthetic Biologics
  6.10.2 Microbiome Therapeutics Product Type, Application and Specification
    6.10.2.1 Probiotic Type
    6.10.2.2 Fructo-Oligosaccharides
  6.10.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 4D Pharma
6.12 AbbVie
6.13 ActoGeniX
6.14 Admera Health
6.15 Advanced Technology Ventures
6.16 Advancing Bio
6.17 AgBiome
6.18 AOBiome
6.19 APC Microbiome Institute
6.20 Assembly Biosciences
6.21 Avid Biotics
6.22 Azitra

7 MICROBIOME THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Microbiome Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Microbiome Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Microbiome Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MICROBIOME THERAPEUTICS MARKET FORECAST (2017-2022)

11.1 United States Microbiome Therapeutics Sales, Revenue Forecast (2017-2022)
11.2 United States Microbiome Therapeutics Sales Forecast by Type (2017-2022)
11.3 United States Microbiome Therapeutics Sales Forecast by Application (2017-2022)
11.4 Microbiome Therapeutics Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Microbiome Therapeutics
Table Classification of Microbiome Therapeutics
Figure United States Sales Market Share of Microbiome Therapeutics by Type in 2015
Figure Probiotic Type Picture
Figure Fructo-Oligosaccharides Picture
Figure Galacto-Oligosaccharides Picture
Figure Inulin Picture
Table Application of Microbiome Therapeutics
Figure United States Sales Market Share of Microbiome Therapeutics by Application in 2015
Figure Antibiotic-Associated Diarrhoea (AAD) Examples
Figure Infectious Childhood Diarrhoea Examples
Figure Cholesterol Examples
Figure Inflammatory Bowel Disease (IBD) Examples
Figure Blood Pressure Examples
Figure Lactose Intolerance Examples
Figure Weight Loss Examples
Figure Vitamin Production Examples
Figure Bacterial Vaginosis (BV) Examples
Figure Others Examples
Figure United States Microbiome Therapeutics Sales and Growth Rate (2012-2022)
Figure United States Microbiome Therapeutics Revenue and Growth Rate (2012-2022)
Table United States Microbiome Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Microbiome Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Microbiome Therapeutics Sales Share by Manufacturers
Figure 2016 Microbiome Therapeutics Sales Share by Manufacturers
Table United States Microbiome Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Microbiome Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Microbiome Therapeutics Revenue Share by Manufacturers
Table 2016 United States Microbiome Therapeutics Revenue Share by Manufacturers
Table United States Market Microbiome Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Microbiome Therapeutics Average Price of Key Manufacturers in 2015
Figure Microbiome Therapeutics Market Share of Top 3 Manufacturers
Figure Microbiome Therapeutics Market Share of Top 5 Manufacturers
Table United States Microbiome Therapeutics Sales by States (2012-2017)
Table United States Microbiome Therapeutics Sales Share by States (2012-2017)
Figure United States Microbiome Therapeutics Sales Market Share by States in 2015
Table United States Microbiome Therapeutics Revenue and Market Share by States (2012-2017)
Table United States Microbiome Therapeutics Revenue Share by States (2012-2017)
Figure Revenue Market Share of Microbiome Therapeutics by States (2012-2017)
Table United States Microbiome Therapeutics Price by States (2012-2017)
Table United States Microbiome Therapeutics Sales by Type (2012-2017)
Table United States Microbiome Therapeutics Sales Share by Type (2012-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Type in 2015
Table United States Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)
Table United States Microbiome Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Microbiome Therapeutics by Type (2012-2017)
Table United States Microbiome Therapeutics Price by Type (2012-2017)
Figure United States Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Microbiome Therapeutics Sales by Application (2012-2017)
Table United States Microbiome Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Application in 2015
Table United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
Table C3 Jian Basic Information List
Table C3 Jian Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure C3 Jian Microbiome Therapeutics Sales Market Share (2012-2017)
Table Enterome Bioscience Basic Information List
Table Enterome Bioscience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Enterome Bioscience Microbiome Therapeutics Sales Market Share (2012-2017)
Table Immuron Basic Information List
Table Immuron Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Immuron Microbiome Therapeutics Sales Market Share (2012-2017)
Table MicroBiome Therapeutics Basic Information List
Table MicroBiome Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table MicroBiome Therapeutics Microbiome Therapeutics Sales Market Share (2012-2017)
Table OpenBiome Basic Information List
Table OpenBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table OpenBiome Microbiome Therapeutics Sales Market Share (2012-2017)
Table Osel Basic Information List
Table Osel Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Osel Microbiome Therapeutics Sales Market Share (2012-2017)
Table Ritter Pharmaceuticals Basic Information List
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales Market Share (2012-2017)
Table Second Genome Basic Information List
Table Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Second Genome Microbiome Therapeutics Sales Market Share (2012-2017)
Table Seres Therapeutics Basic Information List
Table Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Seres Therapeutics Microbiome Therapeutics Sales Market Share (2012-2017)
Table Synthetic Biologics Basic Information List
Table Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Synthetic Biologics Microbiome Therapeutics Sales Market Share (2012-2017)
Table 4D Pharma Basic Information List
Table AbbVie Basic Information List
Table ActoGeniX Basic Information List
Table Admera Health Basic Information List
Table Advanced Technology Ventures Basic Information List
Table Advancing Bio Basic Information List
Table AgBiome Basic Information List
Table AOBiome Basic Information List
Table APC Microbiome Institute Basic Information List
Table Assembly Biosciences Basic Information List
Table Avid Biotics Basic Information List
Table Azitra Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2015
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders List
Figure United States Microbiome Therapeutics Production and Growth Rate Forecast (2017-2022)
Figure United States Microbiome Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Table United States Microbiome Therapeutics Production Forecast by Type (2017-2022)
Table United States Microbiome Therapeutics Consumption Forecast by Application (2017-2022)
Table United States Microbiome Therapeutics Sales Forecast by States (2017-2022)
Table United States Microbiome Therapeutics Sales Share Forecast by States (2017-2022)